MRS2 and endometrial cancer: Interestingly, MRS2 knockdown did not significantly alter lactate levels in the cell supernatant, suggesting that LPS—but not MRS2—is the primary inducer of lactate production in endometrial cancer cells, as supported by earlier findings in ‘Lactic acid increases ROS production by activating MRS2’ (Fig. 3A).